Synthetic Cannabinoid Toxicity in 2026: What New Clinical Reviews Reveal About K2 Diagnosis and Risk
A new 2026 clinical review warns that synthetic cannabinoid toxicity is often severe and frequently missed by standard diagnostic tools. Here is what the findings mean for recognizing K2 exposure, understanding health risks, and making safer decisions.